VPN Plus+ ExclusiveLess Fear, More Hope: How Research is Driving New Strategies in Hemangiosarcoma Treatment and PreventionDecember 11, 2025In this session: Antonella Borgatti, DVM, MS, DACVIM (Oncology), DECVIM-CA, enlightens attendees with original research from the University of Minnesota on eBAT, a first-in-class bispecific targeted angiotoxin. eBAT is designed to selectively eliminate tumor cells and tumor-initiating cells, offering dual potential as both a therapeutic and preventive option in high-risk canine populations.
SPONSORED CONTENTThe clear reco for hidden stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
FDA conditionally approves drug for treatment of New World screwworm in cattleDecember 8, 2025The fluralaner topical solution is for the prevention and treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis), as well as for the treatment and control of cattle fever tick (Rhipicephalus microplus).
300 cases of dog food recalled due to potential plastic contaminationDecember 8, 2025According to the recall announced by the U.S. Food and Drug Administration (FDA), the product was distributed to pet stores in 14 states in the U.S., and in the Province of Ontario, Canada.
What's ahead for veterinary pharmaDecember 8, 2025Let’s take a look at new drugs reshaping veterinary care and offering breakthrough treatments for chronic conditions and previously untreatable diseases.
Non-invasive tumor detection for dogs improves patient outcomeDecember 8, 2025Adapting new approaches allows veterinary teams to evaluate the risk of tumors in real-time, enabling them to ultimately detect cancer earlier, and more efficiently.
Brain Teaser: Can you solve this puzzle?December 8, 2025Presentation: A nine-year-old spayed female Chihuahua presented after being attacked by a coyote.
VPN Plus+ ExclusiveCut through the noise: Making EBVM work in everyday practiceDecember 3, 2025By engaging in evidence-based practices, we improve the care we provide our patients using recommendations and guidelines developed by specialists and those with the expertise to synthesize the evidence. Gone are the days when we simply prescribed something because that was how we had always done it. Instead, it is our responsibility to base our prescribing practices, procedural care, and other medical and surgical applications upon sound, trustworthy medical information.
VPN Plus+ ExclusiveImmunotherapy in Veterinary Oncology: Past, Present, and FutureNovember 26, 2025In this session: Craig Clifford, DVM, MS, DACVIM (Oncology) discusses key immunotherapeutic strategies, available products, and clinical advancements in veterinary oncology.
Clinical trial evaluates GLP-1 for regulating feline appetiteNovember 26, 2025Cornell University is leading a study to assess a new protein-based therapy intended to help cats reach healthier body condition through once-weekly dosing.
Awareness campaign highlights risks of feline obesityNovember 25, 2025The effort aims to prompt pet owners to work with their veterinarians to monitor their cats’ weight and adopt preventive measures—such as balanced nutrition, regular activity, and routine wellness checks—to support long-term health.
